A comprehensive development program identified stabilising carriers and additives to enable RAPClot™ and other prothrombin activators to be formulated into commercially available tubes with an appropriate shelf-life at room temperature. The formulations have been designed to optimize stability under industrial irradiation conditions.
Formulations combining prothrombin activators, colloid carriers and other stabilising agents are the subject of patents pending.
Q-Sera tubes are designed and manufactured using:
- Standard plastic blood collection tubes
- Standard spray coating techniques for tubes
- Standard irradiation techniques
- Easily sourced formulation components